These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 3334773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use.
    Kjaer SK, Engholm G, Dahl C, Bock JE, Lynge E, Jensen OM.
    Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A.
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [Abstract] [Full Text] [Related]

  • 7. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987 Dec; (Spec No):40-1. PubMed ID: 12269054
    [Abstract] [Full Text] [Related]

  • 8. [Morphofunctional features of the cervix uteri in women using hormonal contraception].
    Prilepskaia VN, Kondrikov NI, Nazarova NM.
    Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptive use and risk of invasive cervical cancer.
    Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, Tenorio F, Garcia M, Rawls WE.
    Int J Epidemiol; 1990 Mar; 19(1):4-11. PubMed ID: 2351522
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral contraceptives and neoplasia.
    Stubblefield PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
    [Abstract] [Full Text] [Related]

  • 14. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives and cancer.
    Edgren RA.
    Int J Fertil; 1991 Jan; 36 Suppl 3():37-50. PubMed ID: 1687403
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
    Vessey M, Yeates D.
    Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M.
    Br J Cancer; 2001 May 04; 84(9):1219-26. PubMed ID: 11336474
    [Abstract] [Full Text] [Related]

  • 19. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia.
    La Vecchia C.
    Contraception; 1994 Mar 04; 49(3):223-30. PubMed ID: 8200216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.